Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CGEM has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
CGEM stock price ended at $8.645 on Friday, after losing-0.4%
The Cullinan Oncology Inc stock price decreased by -0.4% on the last trading day (30 May 2025), dropping from 8.57 to 8.645. Throughout the last trading session, the stock experienced a fluctuation of 7.01% , ranging from a day low of $8.27 to a day high of 8.85. The price has declined in 3 of the last 10 days, resulting in a total change of 19.41% during this period. On the last day, trading volume decrease by -15.13K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 594.56K shares were traded, amounting to approximately 5.11M.
CGEM Technical Signals
CGEM(Cullinan Oncology Inc Corp) has 5 buy signals and 4 sell signals now. The current trend is uptrend starting from 2025-05-15. The total price change during this trend is +19.41%. Recently, the price has decreased but the volume has also decreased, indicating a potential rebound signal. The average turnover of CGEM over the last 5 trading days is 3.34M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
CGEM Moving Average Analysis
Cullinan Oncology Inc's overall moving average trend leans more bullish as of Friday, May 30, 2025, with 2 negative signals and 2 positive signal. In the mid-term, the SMA_20 being below the SMA_60 signals a strong bearish trend. There will be some resistance from the lines at $9.07644, and $9.775500000000001. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $6.81456, and $6.1155. A break-down below any of these levels will issue sell signals.
CGEM Short Selling Analysis
The short sale ratio of Cullinan Oncology Inc(CGEM) as of 27 May 2025 is 9.03%, dropping from last trading day. With decreasing price from 7.81 to 7.82. The short sell activity indicate that short sellers may be experiencing short cover.
Technical Signal
Technical Signals Summary
Neutral
Sell
4
Buy
5
Moving Average
Swing
Positive
Stock Price Above SMA_5
Short Term
Positive
SMA_5 Above SMA_20
Mid Term
Negative
SMA_20 Below SMA_60
Long Term
Positive
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
5 Bullish Signals
5 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
0.137
Bullish
Momentum (10 days)
MOM_10 > 0
1.405
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
0.071
Bullish
Moving Average
5-day SMA crosses above 60-day SMA
--
Bullish
Moving Average
10-day SMA crosses above 20-day SMA
--
Bullish
4 Bearish Signals
4 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Stochastic Oscillator %K (14, 3, 3)
STOCHk_14_3_3 > 80
87.891
Bearish
Commodity Channel Index (20 days, 0.015 constant)
CCI_20_0.015 > 100
173.979
Bearish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 > 80
96.486
Bearish
Williams %R (14 days)
WILLR_14 > -20
-10.302
Bearish
CGEM Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Cullinan Oncology Inc(CGEM), our algorithm predicts CGEM's 1-month price at $7.44, with an -0.76%downwardshift. Using a similarity score up to 91.52%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Cullinan Oncology Inc (CGEM.O) stock, as of Sunday, May 18, 2025 , forecasts a -0.76% change over the next month, based on its high correlation with AMED.O stock patterns. The similarity between their price movements over the analyzed periods is 91.52%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
CGEM
Future prediction
Up: -0.76%
AMED
Down: -0.76%Similarity: 91.52%
Name
Similarity
Up/Down
AMED.O
91.52%
-0.76%
CSTM.N
90.61%
+7.60%
NOA.N
90.47%
+17.19%
KEYS.N
90.13%
+5.84%
MRKR.O
90.11%
-19.13%
BF.B.N
90.00%
+1.88%
CGEM Seasonality Analysis
Based on CGEM's historical stock price data across all years, the probability of a positive return in May is60.00%, suggesting it maybe an ideal month to invest in CGEM. In contrast,Mayoffers the highest probability of positive returns at60.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Cullinan Oncology Inc (CGEM.O) stock in May has the highest probability of a positive return (60.00%), while September has the lowest probability (0.00%).
Performance Seasonality
The chart shows Cullinan Oncology Inc. (CGEM)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
Should I buy Cullinan Oncology Inc (CGEM.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. CGEM has several negative signals and is within a falling trend, so we believe it will perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Our analysis conclusion for this stock is a Strong Sell candidate.
Which months have the highest win rate for buying Cullinan Oncology Inc (CGEM.O) stock in a year?
The radar chart shows that buying Cullinan Oncology Inc (CGEM.O) stock in May has the highest probability of a positive return (60.00%), while September has the lowest probability (0.00%).
How has Cullinan Oncology Inc. (CGEM)'s stock price performed over the past three years?
CGEM's stock price fell by -4.59% in 2023,increased by 15.01% in 2024, and went down by 30.23% in 2025.
Which bull technical signals does CGEM have?
Bullish technical signals of CGEM include: AO_5_34 > 0, MOM_10 > 0, MACD_12_26_9 > 0, 5-day SMA crosses above 60-day SMA, 10-day SMA crosses above 20-day SMA.
Is CGEM a buy based on overall technical signals summary?
CGEM has 5 buy signals and 4 sell signals now. Overall the technical rating for CGEM is Neutral . Note that market conditions change all the time. In addition to technical ratings, keep an eye on the Valuation Level of CGEM.
What is the trend of Cullinan Oncology Inc (CGEM)'s moving average?
Cullinan Oncology Inc's overall moving average trend leans more bullish as of May 30 2025, with 2 negative signals and 2 positive signal.
What is price prediction for CGEM stock next month?
The price prediction chart for Cullinan Oncology Inc (CGEM.O) stock, as of May 18 2025, forecasts a -0.76% change over the next month, based on its high correlation with AMED stock patterns. The similarity between their price movements over the analyzed periods is 91.52%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.
What is price prediction 2025 for CGEM Stock?
### **Price Prediction for CGEM Stock in 2025**
CGEM stock is expected to trade between **$6.20 and $8.90** in 2025.
The stock is currently near the lower end of its Bollinger Bands, suggesting potential undervaluation.
Recent clinical trial approvals and pipeline progress could drive upside.
What is price prediction 2030 for CGEM Stock?
### **Price Prediction for CGEM Stock by 2030**
Based on current trends and analysis, here is a concise price prediction for CGEM stock by 2030:
1. **Bullish Case**: $15.00 - Driven by successful clinical trials and strong market adoption of CGEM's therapeutic pipeline, particularly for rheumatoid arthritis and lupus treatments.
2. **Base Case**: $12.00 - Reflects moderate growth with steady progress in clinical developments and stable market conditions.
3. **Bearish Case**: $8.00 - If CGEM faces setbacks in clinical trials or increased competition in the biotech sector.